Your address will show here +12 34 56 78
Uncategorized
The 2025 IMCAS World Congress, one of the most anticipated events in the dermatology and aging science community, is set to take place in Paris from January 30 to February 1, 2025. This global gathering will showcase the latest breakthroughs and innovations in the field, featuring over 350 exhibitors presenting cutting-edge products and technologies.

In an exciting development, Avisé Labs is thrilled to announce that their CEO will be presenting alongside Stanford Professor Anne L. Chang at this year’s IMCAS World Congress. The presentation will take place as part of the Skin & Digital Summit, a key focus area of the congress.

The talk, titled „What You See Is Not What You Get: Why Image Data Alone Falls Short & Key Factors for Machine Learning Success,“ promises to be a thought-provoking exploration of the complexities involved in leveraging artificial intelligence in dermatology. Professor Chang, known for her expertise in dermatology and her work as the Founding Director of the Advanced Basal Cell Carcinoma Clinic and co-founding director of the Skin Longevity Program at Stanford, brings a wealth of experience in clinical trials and translational research to the discussion. Her background in investigating mechanisms underlying skin aging, rejuvenation, and longevity will undoubtedly provide valuable insights.

This collaboration between industry and academia exemplifies the innovative spirit of IMCAS World Congress, fostering discussions that bridge cutting-edge technology with clinical expertise. The congress aims to showcase not only the highest quality and factually valid science but also the latest developments and areas of expansion in dermatology and aging science. With sessions covering a wide range of topics from clinical dermatology and lasers to practice management and ethics, IMCAS 2025 promises to offer valuable insights for all attendees.

For those interested in attending this groundbreaking presentation and exploring the intersection of AI and dermatology, more information can be found on the official IMCAS website: https://www.imcas.com/en/attend/imcas-world-congress-2025/program/session/55783
0

Uncategorized

The German AI Startup Landscape is Germany’s most comprehensive and respected analysis of the AI startup scene, highlighting the incredible work being done by the AI startups across various enterprise functions, technologies, and industries.

This year, Deutsche Telekom, NVIDIA, Intel Corporation, UnternehmerTUM, Cherry Ventures, Earlybird Venture Capital, UVC Partners, Yttrium, HTGF | High-Tech Gründerfonds, eCapital Corp., Burda Principal Investments, HV Capital, D11Z. Ventures GmbH & Co. KG., MIG Capital and the AI.FUND participated in the selection process of the most promising AI startups in Germany.

You can find further information about the selection process as well as a detailed analysis of the German AI Startup Landscape here: https://lnkd.in/eXmq4KuP

Also, the  WirtschaftsWoche  covered the AI Startup Landscape 2024. Please find the articles in the following:
  1. https://www.wiwo.de/technologie/digitale-welt/kuenstliche-intelligenz-das-sind-deutschlands-ki-hochburgen-/29920056.html 
  2. https://www.wiwo.de/technologie/digitale-welt/kuenstliche-intelligenz-die-27-vielversprechendsten-ki-start-ups-in-deutschland/29919936.html 
  3. https://www.wiwo.de/technologie/digitale-welt/start-up-landschaft-bei-ki-erlebt-deutschland-eine-neue-gruenderzeit/29917562.html
Again, also this year, we are thrilled that the appliedAI Institute and their partners selected avisé labs again in 2024 as one of the most promising AI Startups in Germany!  

We are proud of being part of the AI Startup Landscape and are looking forward to great collaborations and future projects within the AI startup community!
0

Uncategorized

Artificial intelligence (AI) and genetic tests will revolutionize diagnostics and therapies in aesthetic medicine in future. The German magazine “Bild der Frau” writes about avisé and its vision to bring artificial intelligence and aesthetic medicine together.
One research goal is to make skin analysis clearer and more transparent for medical specialists.

Read the article (german only) HERE

0